Tony Kim adds BlackRock Science & Technology Term Trust (NYSE: BSTZ) shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
BlackRock Science & Technology Term Trust portfolio manager Tony Kim reported buying additional common shares of BSTZ. On February 5, 2026, he purchased 41,525 shares at $22 per share and 300 shares at $21.96 per share. The filing shows directly owned positions of 251,554.3651 and 210,029.3651 common shares following the respective transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 41,825 shares ($920,138)
Net Buy
2 txns
Insider
Kim Tony
Role
Insider
Bought
41,825 shs ($920K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 41,525 | $22.00 | $914K |
| Purchase | Common Stock | 300 | $21.96 | $7K |
Holdings After Transaction:
Common Stock — 251,554.365 shares (Direct)
Footnotes (1)
FAQ
What insider activity did BSTZ portfolio manager Tony Kim report?
Tony Kim reported buying additional BSTZ common stock. On February 5, 2026, he acquired 41,525 shares at $22 per share and 300 shares at $21.96 per share, increasing the directly owned positions disclosed in this Form 4 filing.
What are Tony Kim’s BSTZ holdings after the reported insider purchases?
After the reported transactions, the Form 4 lists two direct BSTZ common stock positions. One entry shows 251,554.3651 shares and the other shows 210,029.3651 shares directly owned following the respective February 5, 2026 purchases.
What role does Tony Kim have at BlackRock Science & Technology Term Trust (BSTZ)?
Tony Kim is identified as a portfolio manager for BlackRock Science & Technology Term Trust. In this capacity he filed a Form 4 disclosing personal purchases of BSTZ common stock, reflecting changes in his directly owned share positions.
Is Tony Kim’s BSTZ Form 4 filing a buy or sell transaction?
The Form 4 reflects insider purchases of BSTZ shares by Tony Kim. Both transactions are coded “P” for purchase, covering 41,525 shares at $22 and 300 shares at $21.96, and they are reported as directly owned common stock positions.